REG - Iofina PLC - Director/PDMR Shareholding

IofinaAnnouncement

24/02/2021 07:00

RNS Number : 1054Q
  
Iofina PLC
  
24 February 2021
  
 

 
24 February 2021
 
Iofina plc
("Iofina" or the "Company")
Director/PDMR Dealing
Iofina plc (AIM: IOF) announces that it received notification on 23 February 2021 that Thomas M Becker, Chief Executive Officer and President of the Company, purchased a total of 30,680 ordinary shares in the capital of the Company at an aggregated price of 11.90 pence per share. Further details are set out in the Notification of Dealing Form below.
Following the purchase, Dr. Becker holds 124,430 shares, representing approximately 0.065 per cent. of the Company's share capital. The shares purchased represent 0.016 per cent. of the Company's issued share capital.



Director/PDMR


Ordinary shares purchased


Resultant interest in ordinary shares


Resultant percentage of issued ordinary shares




Non-Executive Chairman


30,680


124,430


0.065%



 
 
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
 
 
Enquiries:
 
Dr. Tom Becker
CEO & President
Iofina plc
Tel: +1 859 356 8000
 
Christopher Raggett/Giles Rolls/Matthew Radley
Tim Redfern (ECM)
finnCap Ltd
Tel: +44 (0)20 7220 0500
 
Media Contact:
Charles Goodwin/Joe Burgess
Yellow Jersey PR Limited
Tel: +44 (0)7747 788 221
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them



1


Details of the persons discharging managerial responsibilities / person closely associated
 




a)


Name
 


Thomas M Becker




2


Reason for the notification
 




a)


Position/Status
 


PDMR - Chief Executive Officer and President




b)


Initial notification/ Amendment
 


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)


Name
 


Iofina plc




b)


LEI
 


213800QDMFYVRJYYTQ84




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 




a)


Description of the financial
instrument, type of
instrument
 
Identification code
 
 


 
 
Ordinary shares of £0.01 each
 
GB00B2QL5C79




b)


Nature of the transaction


Purchase of ordinary shares
 




c)


Price(s) and volume(s)
 


 



Price(s) (p)


Volume(s)




11.75p


100




11.75p


580




11.90p


30,000



 




d)


Aggregated information
 
-     Aggregated volume
 
-     Price
 


 
 
30,680
 
 
11.9p




e)


Date of transaction
 


22 February 2021 and 23 February 2021
 




f)


Place of transaction
 


London Stock Exchange, AIM Market (XLON)
 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBIGDDSDDDGBX